Cancer Types
& Treatment
Directions
& Facilities
Our
Team
Research
& Clinical Trials
TakeCharge!
Home
GO
Clinical Trials
Choosing to participate in a Clinical Trial is a very personal decision – and something you and your entire Moffitt care team can decide together.
Find a Researcher
Research Disciplines
Programs
Departments
Centers of Excellence
Working Groups
Clinical Trials
Clinical Trial Definitions
Informed Consent
Patient Protection
Ten Things to Know
Questions to Ask Your Doctor
Hematology Clinical Trials
Clinical Trials Video
Consortia and Co-Op Groups
Clinical Trials Administration
Research Cores & Technology
Current Research
Partnerships & Studies
ICARE
Ponce School of Medicine
Physical Science Oncology Center
Tampa Bay Community Center Network
M2Gen
Path to Commercialization
Business of Biotech
2013 Event Info
Registration
Department of Oncologic Sciences
Education & Training
Cancer Control Journal
Funding Opportunities
Events in Research
Clinical Trials
Where You Are:
Home
>
Research & Clinical Trials
>
Clinical Trials
Search Clinical Trials
BY CANCER
OR
BY DRUG
OR
STUDY TITLE
(KEYWORD)
(Optional) Show only results for open trials at:
Moffitt Only
Affiliates Only
Select Cancer Type
Anus
Leukemia, not otherwise specified
Other Hematopoietic
Any Site
Leukemia, other
Other Male Genital
Bladder
Lip, Oral Cavity and Pharynx
Other Respiratory and Intrathoracic Organs
Bones and Joints
Liver
Other Skin
Brain and Nervous System
Lung
Other Urinary
Breast - Female
Lymphoid Leukemia
Ovary
Breast - Male
Melanoma, skin
Pancreas
Cervix Uteri
Multiple Myeloma
Prostate
Colon
Mycosis Fungoides
Rectum
Corpus Uteri
Myeloid and Monocytic Leukemia
Small Intestine
Esophagus
Non-Hodgkin's Lymphoma
Soft Tissue
Eye and Orbit
Other Digestive Organ
Stomach
Hodgkin's Lymphoma
Other Endocrine System
Thyroid
Kidney
Other Female Genital
Unknown Sites
Larynx
Select Drug Type
177Lu-DOTA0-Ty3-Octreotate
Eltrombopag olamine
PCI-32765
18F-fluoromisonidazole
Erbitux
PCV13
1-Methyl-D-tryptophan
Eribulin Mesylate
PD 0332991
5-fluorouracil
everolimus
Peg-asparaginase
6-mercaptopurine
Faslodex
Pemetrexed
ACE-011
Fidaxomicin
PF-04449913
Ad.p53 DC
FK228
Placebo
Adcetris
FK506
Plerixafor
Adriamycin
Flavopiridol
PLX-4032
AGS-003
fludarabine
Poly IC-LC
Aldesleukin
Fluticasone
Polyphenon E
Alimta
FOLFIRI
Pomalidomide
Alisertib
FOLFOX
Pralatrexate
Alkeran
fulvestrant
prednisone
Alpharadin
Gardasil
Procarbazine
ALT-801
G-CSF
Proleukin
AMD3100
gemcitabine
PS-341
AMG 386
Gemtuzumab Ozogamicin
Purified Isofavones/placebo
AMG 655
Gemzar
PV-10
AP23573
GM.CD40L
PX-866
ARQ 197
GM.CD40L.CCL21
PXD101
ARRY-614
GM-CSF
RAD001
Arsenic Trioxide
goserelin acetate
Radium-223 chloride
AS15 ASCI
gp 100:209-217(210) Peptide
Rapamune
ATG
gp 100:280-288 (288V) Peptide
Rapamycin
ATRA
GSK2118436
recMAGE-A3 + AS15 ASCI
Autologous Dendritic Cells
GSK2241658A
recNY-ESO-1
Avastin
Gw572016
Regorafenib
axitinib
Ibritumomab tiuxetan
Revlimid
AZD2171
Idarubicin
RGI-2001
Azithromycin
IL-2
Ridaforolimus
BAY 43-9006
Indoximod
Rituxan
BAY 73-4506
In-epratuzumab
rituximab
BAY 80-6946
interferon alpha 2b
RO5185426
BCG
Interleukin-2
Romidepsin
Belinostat
IPI-504
Ruxolitinib
Bevacizumab
Ipilimumab
SAHA
Bexarotene
irinotecan
sargramostatin
BEZ235
Jakafi
SGN-35
BKM120
Jevtana
SGN-CD19A
BMS-936558
KB004
Sirolimus
BMS-936564
KPT-330
SOM230
BMS-982470
KW-0761
Sorafenib
BMS-986015
Lapatinib
Sotatercept
Bortezomib
LCL 161
Standard of Care
Brentuximab vedotin
LDE225
suberoylanilide hydroxamic acid
busulfan
lenalidomide
Sunitinib Malate
BYM338
Leukine
Sylatron
Cabazitaxel
Leuprolide
Tacrolimus
Cabozantinib
LGX818
Taxol
Camptosar
Liposomal Cisplatin
Taxotere
capecitabine
MART-1:26-35(27L) Peptide
Temodal
carboplatin
MDX-1106
Temozolomide
CC-115
MEDI4736
Temsirolimus
CC-223
MEGF0444A
TH-302
CC-4047
MEK162
TIL
CC-5013
Melphalan
Tivantinib
CCI-779
Metformin
TKI258
Cediranib
methotrexate
Topotecan
Cetuximab
Methylprednisolone
Trabectedin
CH5424802
mitoxantrone
Trisenox
cisplatin
MK-1775
U3-1287
CPT-11
MK-3475
Unconjugated Epratuzumab
CPX-351
MK-8242
US-ATG-F
CRS-207
MK-8669
Ustekinumab/placebo
Custirsen sodium
MLN0264
V503
cyclophosphamide
Montanide ISA 51 VG
Valrubicin
Cyclosporine
montelukast
Valstar
Cytarabine
MORAb-004
Velban
Cytosine Arabinoside
Mozobil
Velcade
cytoxan
MPDL3280A
Veliparib
Dacarbazine
Mylotarg
Veltuzamab
Dasatinib
NeuVax
Vemurafenib
Daunomycin
Nilotinib
Vinblastine
daunorubicin
Nivolumab
Vincristine
Decavac
Not Applicable
Vorinostat
decitabine
Novantrone
Vosaroxin
Dexamethasone
NY-ESO-1:157-165(165V) Peptide
Xeloda
DN24-02
octreotide LAR
XL888
docetaxel
Ofatumumab
Y-Epratuzumab Tetraxetan
Dovitinib
OSI-906
Yervoy
Doxil
Other
Yondelis
doxorubicin
paclitaxel
Zelboraf
doxorubicin liposome
Paraplatin
Zevados
DTIC
pasireotide LAR
Zoladex
E7080
Patritumab
Zolinza
Eligard
Pazopanib